[go: up one dir, main page]

SE9801368D0 - New use - Google Patents

New use

Info

Publication number
SE9801368D0
SE9801368D0 SE9801368A SE9801368A SE9801368D0 SE 9801368 D0 SE9801368 D0 SE 9801368D0 SE 9801368 A SE9801368 A SE 9801368A SE 9801368 A SE9801368 A SE 9801368A SE 9801368 D0 SE9801368 D0 SE 9801368D0
Authority
SE
Sweden
Prior art keywords
value
glucocorticosteroid
reversibility
copd
patients
Prior art date
Application number
SE9801368A
Other languages
English (en)
Inventor
Ralph Brattsand
Stefan Ohlsson
Carl Goeran Persson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9801368A priority Critical patent/SE9801368D0/sv
Publication of SE9801368D0 publication Critical patent/SE9801368D0/sv
Priority to JP2000544330A priority patent/JP2002512193A/ja
Priority to PCT/SE1999/000426 priority patent/WO1999053926A1/en
Priority to HK02100375.3A priority patent/HK1038703A1/zh
Priority to BR9909786-9A priority patent/BR9909786A/pt
Priority to EP99912204A priority patent/EP1073441A1/en
Priority to AU30625/99A priority patent/AU3062599A/en
Priority to CN99807636A priority patent/CN1306429A/zh
Priority to CA002329008A priority patent/CA2329008A1/en
Priority to ARP990101816A priority patent/AR018191A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9801368A 1998-04-20 1998-04-20 New use SE9801368D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9801368A SE9801368D0 (sv) 1998-04-20 1998-04-20 New use
JP2000544330A JP2002512193A (ja) 1998-04-20 1999-03-18 軽度／初期型のｃｏｐｄ（慢性閉塞性肺疾患）を処置することを目的とした薬物の製造のための糖質副腎皮質ステロイドの使用
PCT/SE1999/000426 WO1999053926A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
HK02100375.3A HK1038703A1 (zh) 1998-04-20 1999-03-18 糖皮質類固醇在制備治療輕度/早期copd(慢性阻塞性肺病)的藥物中的應用
BR9909786-9A BR9909786A (pt) 1998-04-20 1999-03-18 Utilização de um glucocorticosteroide para a fabricação de um medicamento para tratar formas brandas/ precoces de copd (doença pulmonarobstrutiva crÈnica
EP99912204A EP1073441A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
AU30625/99A AU3062599A (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
CN99807636A CN1306429A (zh) 1998-04-20 1999-03-18 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用
CA002329008A CA2329008A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
ARP990101816A AR018191A1 (es) 1998-04-20 1999-04-20 Uso de glucocorticosteroides para la manufactura de un medicamento para tratar enfermedades pulmonares obstructivas cronicas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801368A SE9801368D0 (sv) 1998-04-20 1998-04-20 New use

Publications (1)

Publication Number Publication Date
SE9801368D0 true SE9801368D0 (sv) 1998-04-20

Family

ID=20411015

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801368A SE9801368D0 (sv) 1998-04-20 1998-04-20 New use

Country Status (10)

Country Link
EP (1) EP1073441A1 (sv)
JP (1) JP2002512193A (sv)
CN (1) CN1306429A (sv)
AR (1) AR018191A1 (sv)
AU (1) AU3062599A (sv)
BR (1) BR9909786A (sv)
CA (1) CA2329008A1 (sv)
HK (1) HK1038703A1 (sv)
SE (1) SE9801368D0 (sv)
WO (1) WO1999053926A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912534D0 (en) 1999-05-29 1999-07-28 Glaxo Group Res Ltd Novel prognostic surrogate
ECSP003747A (es) * 1999-11-02 2002-05-23 Smithkline Beecham Corp Metodo y composiciones para el tratamiento de las enfermedades pulmonares
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
WO2004070058A1 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DK1670482T4 (da) 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
JP2007506768A (ja) * 2003-09-26 2007-03-22 シェーリング　コーポレイション 肺疾患処置
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用

Also Published As

Publication number Publication date
WO1999053926A1 (en) 1999-10-28
JP2002512193A (ja) 2002-04-23
AU3062599A (en) 1999-11-08
BR9909786A (pt) 2000-12-19
AR018191A1 (es) 2001-10-31
CA2329008A1 (en) 1999-10-28
EP1073441A1 (en) 2001-02-07
HK1038703A1 (zh) 2002-03-28
CN1306429A (zh) 2001-08-01

Similar Documents

Publication Publication Date Title
AU684087B2 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
CY1105199T1 (el) Θepαπευτικες συνθεσεις για αντιμετωπιση της υπepεκκρισης βλεννας
ATE252912T1 (de) Pharmazeutische zusammensetzung zur behandlung einer funktionalen dyspepsie und/oder des reizdarmsyndroms und die verwendung neuer substanzen in dieser zusammensetzung
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
EA200700232A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
Fragen et al. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty.
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
SE9801368D0 (sv) New use
WO2004100878A3 (en) Method of treatment of hemorrhagic disease using a factor viia/tissue factor inhibitor
PE11399A1 (es) Combinacion de loratadina y un descongestionante para el tratamiento del asma
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
Harper et al. Non-union of Colles' fracture: report of two cases
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
WO2002039999B1 (en) Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
Ejnell et al. Treatment of postoperative pain with diclofenac in uvulopalatopharyngoplasty
SE9902597D0 (sv) New use
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
RU98114080A (ru) Биологически активные этанамины бензотиазолона